Burns v. Friedli

241 F. Supp. 2d 519, 2003 U.S. Dist. LEXIS 1057, 2003 WL 168601
CourtDistrict Court, D. Maryland
DecidedJanuary 10, 2003
DocketCIV.A. CCB-02-1649
StatusPublished

This text of 241 F. Supp. 2d 519 (Burns v. Friedli) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Burns v. Friedli, 241 F. Supp. 2d 519, 2003 U.S. Dist. LEXIS 1057, 2003 WL 168601 (D. Md. 2003).

Opinion

MEMORANDUM

BLAKE, District Judge.

Now pending before the court are plaintiffs’ motion to remand and defendants’ motions to dismiss. The motions have been fully briefed and oral argument was held on November 22, 2002. A brief description of the case is as follows.

Defendant Osiris Therapeutics, Inc. (“Osiris”) is a commercial stem cell company established in 1992 that focuses on “cellular therapeutic products for the regeneration and restoration of damaged and diseased tissue.” (Compl. at ¶¶ 1, 27, 30). Plaintiff James S. Burns (“Burns”) is a founder and former president and chief executive officer of Osiris. (Id. at ¶ 27). Burns sued Osiris, MSC Regenos AG (“MSC-R”), the parent company of Osiris, and Peter Friedli (“Friedli”) and Max Link (“Link”), directors of Osiris and MSC-R, both derivatively and on behalf of a class comprised of the minority shareholders of Osiris and MSC-R. (Id. at ¶¶ 1-2, 5-7, 11, 28-29). The complaint alleges, in sum, that Friedli and Link engaged in a number of unlawful transactions for their own personal gain and at the expense of Osiris and its minority shareholders. (Id. at ¶¶ 1-3). Specifically, they are accused of “extracting] large sums of money from Osiris in the form of various ‘fees,’ consulting contracts, and inflated expense reimbursements,” “deliberately and repeatedly precipitating] financial crises at the company to enable [them] and affiliated organizations to gain a stranglehold over the company,” “engaging] in unlawful self-dealing,” “consummating] an unlawful merger calculated to squeeze out minority shareholders,” and “concealing] material information from their fellow Osiris directors and shareholders.” (Id. at ¶ 2; see also, id. at ¶¶ 35-73).

As stated, the complaint includes both derivative and class claims. Counts I through IV are derivative claims (breach of fiduciary duty of care, breach of fiducia *521 ry duty of loyalty, breach of fiduciary duty of good faith, and breach of fiduciary duty of disclosure), while Counts V through X are class claims (common law fraud, negligent misrepresentation, breach of fiduciary duty of care, breach of fiduciary duty of loyalty, breach of fiduciary duty of good faith, and breach of fiduciary duty of disclosure). (Id. at ¶¶ 74-121).

Burns brought this action in the Circuit Court for Baltimore City (see Compl.), but the defendants removed it to this court on the basis of diversity jurisdiction (see Notice of Removal). 1 Burns is a citizen of Maryland, MSC-R is a Swiss entity, and Friedli and Link are citizens of Switzerland. (Compl. at ¶¶ 4-7). Osiris is a Delaware corporation with its principal place of business in Maryland. (Id. at ¶ 8). For jurisdictional purposes, therefore, Defendant Osiris, like Plaintiff Burns, is a citizen of Maryland. See 28 U.S.C. § 1332(c).

Accordingly, plaintiffs move to remand the case to state court. (See Pis.’ Mot. to Remand). The defendants contend, by way of opposition memoranda and motions to dismiss, that Osiris was fraudulently joined as a defendant to defeat diversity jurisdiction. (See, e.g., Osiris’s Mot. to Dismiss). According to the defendants, the complaint does not state valid derivative or class claims against Osiris, and, thus, the case should be dismissed as against it and this court should exercise jurisdiction over the matter. (Id.).

As the Fourth Circuit has explained, a removing defendant seeking to show fraudulent joinder “must demonstrate either ‘outright fraud in the plaintiffs pleading of jurisdictional facts’ or that ‘there is no possibility that the plaintiff would be able to establish a cause of action against the in-state defendant in state court.’ ” Hartley v. CSX Transp., Inc., 187 F.3d 422, 424 (4th Cir.1999) (quoting Marshall v. Manville Sales Corp., 6 F.3d 229, 232 (4th Cir.1993) (emphasis in original)). As there is no claim of outright fraud in this case, the defendants bear the “heavy burden” of showing that the plaintiffs cannot establish a claim against the non-diverse defendant Osiris “even after resolving all issues of law and fact in the plaintiff[s’] favor.” Hartley, 187 F.3d at 424 (citing Marshall, 6 F.3d at 232-33). “[Ultimate success is not required to defeat removal. Rather, there need be only a slight possibility of a right to relief’ to warrant remanding the case to state court. Hartley, 187 F.3d at 426 (internal citations omitted). This standard is even more favorable to plaintiffs than the one used to evaluate motions to dismiss pursuant to Rule' 12(b)(6) of the Federal Rules of Civil Procedure. Id. at 424.

Class claims

Defendants advance two arguments to support their contention that plaintiffs, cannot state any class claims against Osiris. First, defendants assert that the complaint does not contain any bona fide class claims (as distinguished from derivative claims) because the plaintiffs failed to allege any individual harm. (See Friedli’s Mot. to Dismiss at 9-12; Friedli’s Reply Mem. at 9-10; Link’s Mot. to Dismiss at 6-7). Second, defendants submit that Osiris is not a necessary party to the class claims, which seem to be directed against Friedli and Link. (See Osiris’s Mot. to Dismiss at 9-11; Osiris’s Mem. in Opp. to Pis.’ Mot. for Remand at 10-13).

Regarding the first argument, defendants maintain that in order to sustain a cognizable class claim, a plaintiff “must *522 ‘allege more than an injury resulting from a wrong to the corporation;’ he must plead [a] ‘special injury’... unique to the individual shareholder.” (Friedli’s Mot. to Dismiss at 10) (quoting Kramer v. W. Pac. Indus., Inc., 546 A.2d 348, 351-52 (Del.1988)). 2 In Kramer, 546 A.2d at 353, the Supreme Court of Delaware explained that a claim of mismanagement resulting in an overall depression of stock value is properly brought as a derivative action because such devaluation is “a wrong to the corporation; i.e., the stockholders collectively.” Contrarily, a plaintiff who “directly attacks the fairness or validity of a merger alleges an injury to the stockholders, not the corporation,” and, thus, may maintain direct class claims. Parnes v. Bally Entm’t Corp., 722 A.2d 1243, 1245 (Del.1999) (citing Lewis v. Anderson, 477 A.2d 1040, 1046, n. 10 (Del.1984)). To state a valid class claim challenging a merger, plaintiffs “usually...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Smith v. Sperling
354 U.S. 91 (Supreme Court, 1957)
Parnes v. Bally Entertainment Corp.
722 A.2d 1243 (Supreme Court of Delaware, 1999)
Lewis v. Anderson
477 A.2d 1040 (Supreme Court of Delaware, 1984)
Martin v. Carl
132 A.2d 601 (Court of Appeals of Maryland, 1957)
Birnbaum v. SL & B Optical Centers, Inc.
905 F. Supp. 267 (D. Maryland, 1995)
Scattered Corp. v. Chicago Stock Exchange, Inc.
701 A.2d 70 (Supreme Court of Delaware, 1997)
Grimes v. Donald
673 A.2d 1207 (Supreme Court of Delaware, 1996)
Schreiber v. Carney
447 A.2d 17 (Court of Chancery of Delaware, 1982)
Brehm v. Eisner
746 A.2d 244 (Supreme Court of Delaware, 2000)
Kramer v. Western Pacific Industries, Inc.
546 A.2d 348 (Supreme Court of Delaware, 1988)
Aronson v. Lewis
473 A.2d 805 (Supreme Court of Delaware, 1984)
Parker v. Johnny Tart Enterprises, Inc.
104 F. Supp. 2d 581 (M.D. North Carolina, 1999)
Khoury v. Oppenheimer
540 F. Supp. 737 (D. Delaware, 1982)
Derry Finance N.V. v. Christiana Companies, Inc.
102 F.R.D. 892 (D. Delaware, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
241 F. Supp. 2d 519, 2003 U.S. Dist. LEXIS 1057, 2003 WL 168601, Counsel Stack Legal Research, https://law.counselstack.com/opinion/burns-v-friedli-mdd-2003.